11 million euros for EU research project on inflammatory diseases: Kiel researchers coordinate international cooperation

The new project ‘PerPrev-CID’ investigates innovative approaches for the early diagnosis and personalized prevention of rheumatoid arthritis and inflammatory bowel diseases.

The project is coordinated by the University Hospital Schleswig-Holstein (UKSH), the Faculty of Medicine at Kiel University (CAU) and the Cluster of Excellence ‘Precision Medicine in Chronic Inflammation’ (PMI) and brings together 15 international research institutions from 8 countries. It will receive a total funding of 11 million Euros from the European Union’s Horizon Europe Framework Programme for Research and Innovation over the next five years. 

Scientific coordinator of the PerPrev-CID consortium is Professor Philip Rosenstiel, director of the Institute of Clinical Molecular Biology at UKSH and Kiel University, member of the Cluster of Excellence ‘Precision Medicine in Chronic Inflammation’ (PMI), and vice speaker and principal investigator in miTarget (project P3).

You can find more information in the news section of the PMI homepage or in the original press release.

Photo Prof. Philip Rosenstiel: © Tebke Böschen, PMI